PMID- 9005816 OWN - NLM STAT- MEDLINE DCOM- 19970130 LR - 20190905 IS - 0365-6233 (Print) IS - 0365-6233 (Linking) VI - 329 IP - 3 DP - 1996 Mar TI - New antifolate 4,4'-diaminodiphenyl sulfone substituted 2,4-diamino-5-benzylpyrimidines. Proof of their dual mode of action and autosynergism. PG - 161-8 AB - New 4,4'-diaminodiphenylsulfone substituted 2,4-diamino-5-benzylpyrimidines were synthesized. These compounds are highly active inhibitors of both bacterial dihydrofolate reductase (DHFR) and dihydropteroic acid synthase (SYN). The simultaneous inhibition of both enzymes leads to autosynergism in whole cells in the same way as known for combinations of sulfonamides with trimethoprim. The inhibitory activity is demonstrated in cell-free systems of DHFR and SYN derived from various species (M. lufu, E. coli, C. albicans) and in whole cell systems of the mycobacterial strain M. lufu. The compounds are rare examples for the combination of two mechanisms of action in one molecule. FAU - Wiese, M AU - Wiese M AD - Forschungszentrum Borstel, Zentrum fur Medizin und Biowissenschaften, Germany. FAU - Schmalz, D AU - Schmalz D FAU - Seydel, J K AU - Seydel JK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Germany TA - Arch Pharm (Weinheim) JT - Archiv der Pharmazie JID - 0330167 RN - 0 (Bacterial Proteins) RN - 0 (Enzyme Inhibitors) RN - 0 (Folic Acid Antagonists) RN - 0 (Pyrimidines) RN - 17615-73-5 (SDDS) RN - 8W5C518302 (Dapsone) RN - EC 2.5.1.15 (Dihydropteroate Synthase) SB - IM MH - Bacterial Proteins/metabolism MH - Dapsone/*analogs & derivatives/chemical synthesis/pharmacology MH - Dihydropteroate Synthase/antagonists & inhibitors MH - Drug Synergism MH - Enzyme Inhibitors/chemical synthesis/*pharmacology MH - Folic Acid Antagonists/chemical synthesis/*pharmacology MH - Microbial Sensitivity Tests MH - Pyrimidines/chemical synthesis/*pharmacology EDAT- 1996/03/01 00:00 MHDA- 1996/03/01 00:01 CRDT- 1996/03/01 00:00 PHST- 1996/03/01 00:00 [pubmed] PHST- 1996/03/01 00:01 [medline] PHST- 1996/03/01 00:00 [entrez] AID - 10.1002/ardp.19963290309 [doi] PST - ppublish SO - Arch Pharm (Weinheim). 1996 Mar;329(3):161-8. doi: 10.1002/ardp.19963290309.